Pharmacists' QUM expertise is vital to optimising therapy and preventing harm, says PSA’s newest medicine safety report.

A group of Australia’s leading medicine safety experts is calling for action to reduce avoidable deaths, hospitalisations and quality-of-life impacts caused by unsafe medicine use.

Remaining ‘vigilant’ is the key to disrupting the harmful influences of opioid prescribing to people at risk of addiction, US pharmacist-turned opioid misuse detective Dan Schneider told attendees at PSA21 Virtual today.

Dr Nijole Bernaitis MPS has spent almost three decades in pharmacy, in a career spanning hospital and community settings, ownership, accreditation and a PhD.

Read all about PSA’s announcement on the future of the profession at the FIP Congress this World Pharmacists Day.

Community pharmacies must continue to evolve if they wish to thrive into the future. What does that look like in practice? ‘Fifty cigarettes a day...